Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial
Authors
Keywords
Smoking habits, Depression, Schizophrenia, Drug therapy, Cognitive impairment, Inpatients, Antipsychotics, Suicide
Journal
PLoS One
Volume 11, Issue 1, Pages e0143490
Publisher
Public Library of Science (PLoS)
Online
2016-01-06
DOI
10.1371/journal.pone.0143490
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder
- (2014) A. Eden Evins et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Limited practice effects and evaluation of expectation for change: MATRICS Consensus Cognitive Battery
- (2014) Jarett E. Roseberry et al. SCHIZOPHRENIA RESEARCH
- Cognitive Performance of Individuals With Schizophrenia Across Seven Decades: A Study Using the MATRICS Consensus Cognitive Battery
- (2013) Tarek K. Rajji et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Varenicline, Smoking Cessation, and Neuropsychiatric Adverse Events
- (2013) Robert D. Gibbons et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of Varenicline on Smoking Cessation in Adults With Stably Treated Current or Past Major Depression
- (2013) Robert M. Anthenelli et al. ANNALS OF INTERNAL MEDICINE
- Neuropsychiatric Events with Varenicline: a Modified Prescription-Event Monitoring Study in General Practice in England
- (2013) Yvonne Buggy et al. DRUG SAFETY
- Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia
- (2013) Sungwon Roh et al. PSYCHOPHARMACOLOGY
- Varenicline modulates spatial working memory deficits in smokers with schizophrenia
- (2013) Victoria C. Wing et al. SCHIZOPHRENIA RESEARCH
- Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia
- (2012) Tanya L. Wallace et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder
- (2012) Jill M. Williams et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effects of Moderate-Dose Treatment With Varenicline on Neurobiological and Cognitive Biomarkers in Smokers and Nonsmokers With Schizophrenia or Schizoaffective Disorder
- (2011) L. Elliot Hong ARCHIVES OF GENERAL PSYCHIATRY
- Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
- (2011) Joo-Cheol Shim et al. NEUROPSYCHOPHARMACOLOGY
- Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia
- (2011) Mu-En Liu et al. PSYCHIATRY RESEARCH
- Psychiatric Adverse Events in Randomized, Double-Blind, Placebo-Controlled Clinical Trials of Varenicline
- (2010) Serena Tonstad et al. DRUG SAFETY
- Adjunctive Risperidone for Partially Responsive People with Schizophrenia Treated with Clozapine
- (2010) Elaine Weiner et al. NEUROPSYCHOPHARMACOLOGY
- Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial
- (2010) Richard S.E. Keefe et al. SCHIZOPHRENIA RESEARCH
- Safety and Drug Utilization Profile of Varenicline as Used in General Practice in England
- (2009) Rachna Kasliwal et al. DRUG SAFETY
- Varenicline Treatment for Smokers With Schizophrenia
- (2009) A. Eden Evins et al. JOURNAL OF CLINICAL PSYCHIATRY
- Varenicline Augmentation in Depressed Smokers
- (2009) Noah S. Philip et al. JOURNAL OF CLINICAL PSYCHIATRY
- Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder
- (2009) Robert C. Smith et al. SCHIZOPHRENIA RESEARCH
- The MATRICS Consensus Cognitive Battery, Part 2: Co-Norming and Standardization
- (2008) Robert S. Kern et al. AMERICAN JOURNAL OF PSYCHIATRY
- Hypomania with Agitation Associated with Varenicline Use in Bipolar II Disorder
- (2008) Anne E Morstad et al. ANNALS OF PHARMACOTHERAPY
- Varenicline Improves Mood and Cognition During Smoking Abstinence
- (2008) Freda Patterson et al. BIOLOGICAL PSYCHIATRY
- Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia
- (2008) Lindsay E. Jubelt et al. PSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started